Drug Information Association Logo
Corporate Tagline

Session 5 - Track 3: Digital Signatures, Introduction & Presentation of Identity Management Standards

Track:
Track 03

Day & Time:
October 17, 8:30AM - 10:00AM

Room Number:
Golden West

Type:
Session

Title:
Session 5 - Track 3: Digital Signatures, Introduction & Presentation of Identity Management Standards

Chair(s):
Shari Perlstein, MBA,PMP
Director, Enterprise Records & Information Management
Pfizer, Inc., United States

Description:
In this session you will learn about some of the concerns that should be addressed before implementing digital signatures. It will also explain why standardized identity management is essential to effective pharmaceutical and health care collaboration and can provide access to protected information assets.

Presentation(s) & Speaker(s):
Points to Consider When Using Digital Signatures in GxP Environments
Patricia Miller, MBA
TBD, United States

The Role of Standardized High-Assurance Identity Trust in Biopharmaceutical and Health Care Internet Transactions
Mollie Shields-Uehling
President & CEO
Safe-Biopharma Association, United States

© 2014